Loading provider…
Loading provider…
Neurology Physician in Chicago, IL
NPI: 1003899428Primary Practice Location
JACKSON PARK HOSPITAL
7531 S Stony Island Ave, Chicago, IL
Primary Employer
Southeast Chicago Neurology Associates SC
jacksonparkhospital.org
HQ Phone
Get MD Anil's Phone NumberMobile
Get MD Anil's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
1989 - 2026

American Board of Psychiatry and Neurology
Neurology
American Board of Clinical Pharmacology
Diplomate • 1992 - 1992
1992 - 1992
King George's Medical College
M.D. • 1979 - 1982
1979 - 1982
M.D. • 1979 - 1982
1979 - 1982
King George's/CSM Medical College
Medical School
Until 1977
University of Illinois College of Medicine - Chicago
medicine.uic.edu
1987 - 1988
1987 - 1988
Post-Doctoral Fellowship • 1987 - 1988
1987 - 1988
Erasmus University Rotterdam
Ph.D. • 1992 - 1996
1992 - 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 155 | 421 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 140 | 153 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 99 | 337 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 88 | 164 |
| 5 | 95819Measurement and recording of brain wave (EEG) activity, awake and asleep | 73 | 73 |
Centhaquin antinociception in mice is mediated by α2A- and α2B- but not α2C-adrenoceptors.
Authors: Shaifali Bhalla, Izna Ali, Anil Gulati
Publication Date: 2013-09
A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients.
Authors: Sohrab Naushad Ali
Publication Date: 2021-05-25
Emission of volatile organic compounds from medical equipment inside neonatal incubators.
Lead Sponsor: Pharmazz, Inc.
Intervention / Treatment: DRUG: PMZ-1620 (sovateltide) along with standard treatment, DRUG: Normal Saline along with standard treatment
Lead Sponsor: Pharmazz, Inc.
Intervention / Treatment: DRUG: Centhaquine + Standard Treatment, DRUG: Normal saline + Standard Treatment
Lead Sponsor: Pharmazz, Inc.
Intervention / Treatment: DRUG: PMZ-1620 along with standard treatment, DRUG: Normal Saline along with standard treatment